NCT05030714View on ClinicalTrials.gov

Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Glaucoma
Interventions
DIAGNOSTIC_TEST

Visual Field Testing

Visual field testing using the protocol 24-2 and/or 10-2 Threshold Test

Trial Locations (2)

B3H 2Y9

Victoria General Hopsital - Nova Scotia Health Authority, Halifax

B3L 4W8

Eadie Technologies Inc., Halifax

All Listed Sponsors
lead

Brennan Eadie

OTHER

NCT05030714 - Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study | Biotech Hunter | Biotech Hunter